PHARMACOKINETICS OF PROSTAGLANDIN E1 AND ITS MAIN METABOLITES AFTER INTRACAVERNOUS INJECTION AND SHORT-TERM INFUSION OF PROSTAGLANDIN E1 IN PATIENTS WITH ERECTILE DYSFUNCTION
- 1 October 1997
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 158 (4), 1403-1407
- https://doi.org/10.1016/s0022-5347(01)64226-5
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Dose proportional pharmacokinetics of alprostadil (prostaglandin E1) in healthy volunteers following intravenous infusion.British Journal of Clinical Pharmacology, 1995
- Pharmacokinetics of Vasoactive Substances Administered into the Human Corpus CavernosumJournal of Urology, 1994
- Determination of prostaglandin E1 and its main plasma metabolites 15-keto-prostaglandin E0 and prostaglandin E0 by gas chromatography/negative ion chemical ionization triple-stage quadrupole mass spectrometryJournal of Mass Spectrometry, 1994
- Pharmacological Erection Program Using Prostaglandin E1Journal of Urology, 1991
- Double-blind, cross-over study comparing prostaglandin E1 and papaverine in patients with vasculogenic impotenceUrology, 1991
- Papaverine Hydrochloride in Peripheral Blood and the Degree of Penile ErectionJournal of Urology, 1990
- Dose‐dependent effect and side‐effect of prostaglandin E1 in erectile dysfunction.British Journal of Clinical Pharmacology, 1989
- Prostaglandin 15‐hydroxydehydrogenase Activity in Human Penile Corpora Cavernosa and its Significance in Prostaglandin‐mediated Penile ErectionBritish Journal of Urology, 1989
- Intracavernous Injection of Prostaglandin E1 in Impotent MenJournal of Urology, 1988
- Mechanisms of Venous Occlusion During Canine Penile Erection: An Anatomic DemonstrationJournal of Urology, 1987